Gene expression identifies heterogeneity of metastatic propensity in high-grade soft tissue sarcomas

Keith M Skubitz, Princy Francis, Amy P Skubitz, Xianghua Luo, Mef Nilbert

Research output: Contribution to journalArticle

15 Citations (Scopus)

Abstract

Background: Metastatic propensity of soft tissue sarcoma (STS) is heterogeneous and may be determined by gene expression patterns that do not correlate well with morphology. The authors have reported gene expression patterns that distinguish 2 broad classes of clear cell renal carcinoma (ccRCC-gene set), and other patterns that can distinguish heterogeneity of serous ovarian carcinoma (OVCA-gene set) and aggressive fibromatosis (AF-gene set); however, clinical follow-up data were not available for these samples. Methods: In the current study, gene expression patterns in 73 samples of high-grade STS were examined using spotted cDNA microarray slides that contained 16,000 unique UniGene clusters. Approximately 50% of the genes present in the ccRCC-, OVCA-, and AF-gene sets were also represented in the data from this chip set, and these were combined to form a composite gene set of 278 probes. Results: Hierarchical clustering using this composite gene set suggested the existence of subsets of the STS samples. Analysis revealed differences in the time to development of metastatic disease between the clusters defined by the first branch point of the clustering dendrogram (P =.005), and also among the 4 different clusters defined by the second branch points (P =.001). Conclusions: This approach suggests the existence of >2 subsets of high-grade pleomorphic STS, each with distinct clinical behavior. A composite gene set such as that described here may be useful to stratify STS in clinical trials, and may be of practical utility in patient management.

Original languageEnglish (US)
Pages (from-to)4235-4243
Number of pages9
JournalCancer
Volume118
Issue number17
DOIs
StatePublished - Sep 1 2012

Fingerprint

Sarcoma
Gene Expression
Genes
Cluster Analysis
Aggressive Fibromatosis
Oligonucleotide Array Sequence Analysis
Renal Cell Carcinoma
Clinical Trials
Carcinoma

Keywords

  • gene expression
  • heterogeneity
  • metastasis
  • microarray
  • prognosis
  • sarcoma
  • subgroups

Cite this

Gene expression identifies heterogeneity of metastatic propensity in high-grade soft tissue sarcomas. / Skubitz, Keith M; Francis, Princy; Skubitz, Amy P; Luo, Xianghua; Nilbert, Mef.

In: Cancer, Vol. 118, No. 17, 01.09.2012, p. 4235-4243.

Research output: Contribution to journalArticle

@article{4d76c88c866d4eadbfa250fcc38efa08,
title = "Gene expression identifies heterogeneity of metastatic propensity in high-grade soft tissue sarcomas",
abstract = "Background: Metastatic propensity of soft tissue sarcoma (STS) is heterogeneous and may be determined by gene expression patterns that do not correlate well with morphology. The authors have reported gene expression patterns that distinguish 2 broad classes of clear cell renal carcinoma (ccRCC-gene set), and other patterns that can distinguish heterogeneity of serous ovarian carcinoma (OVCA-gene set) and aggressive fibromatosis (AF-gene set); however, clinical follow-up data were not available for these samples. Methods: In the current study, gene expression patterns in 73 samples of high-grade STS were examined using spotted cDNA microarray slides that contained 16,000 unique UniGene clusters. Approximately 50{\%} of the genes present in the ccRCC-, OVCA-, and AF-gene sets were also represented in the data from this chip set, and these were combined to form a composite gene set of 278 probes. Results: Hierarchical clustering using this composite gene set suggested the existence of subsets of the STS samples. Analysis revealed differences in the time to development of metastatic disease between the clusters defined by the first branch point of the clustering dendrogram (P =.005), and also among the 4 different clusters defined by the second branch points (P =.001). Conclusions: This approach suggests the existence of >2 subsets of high-grade pleomorphic STS, each with distinct clinical behavior. A composite gene set such as that described here may be useful to stratify STS in clinical trials, and may be of practical utility in patient management.",
keywords = "gene expression, heterogeneity, metastasis, microarray, prognosis, sarcoma, subgroups",
author = "Skubitz, {Keith M} and Princy Francis and Skubitz, {Amy P} and Xianghua Luo and Mef Nilbert",
year = "2012",
month = "9",
day = "1",
doi = "10.1002/cncr.26733",
language = "English (US)",
volume = "118",
pages = "4235--4243",
journal = "Cancer",
issn = "0008-543X",
publisher = "John Wiley and Sons Inc.",
number = "17",

}

TY - JOUR

T1 - Gene expression identifies heterogeneity of metastatic propensity in high-grade soft tissue sarcomas

AU - Skubitz, Keith M

AU - Francis, Princy

AU - Skubitz, Amy P

AU - Luo, Xianghua

AU - Nilbert, Mef

PY - 2012/9/1

Y1 - 2012/9/1

N2 - Background: Metastatic propensity of soft tissue sarcoma (STS) is heterogeneous and may be determined by gene expression patterns that do not correlate well with morphology. The authors have reported gene expression patterns that distinguish 2 broad classes of clear cell renal carcinoma (ccRCC-gene set), and other patterns that can distinguish heterogeneity of serous ovarian carcinoma (OVCA-gene set) and aggressive fibromatosis (AF-gene set); however, clinical follow-up data were not available for these samples. Methods: In the current study, gene expression patterns in 73 samples of high-grade STS were examined using spotted cDNA microarray slides that contained 16,000 unique UniGene clusters. Approximately 50% of the genes present in the ccRCC-, OVCA-, and AF-gene sets were also represented in the data from this chip set, and these were combined to form a composite gene set of 278 probes. Results: Hierarchical clustering using this composite gene set suggested the existence of subsets of the STS samples. Analysis revealed differences in the time to development of metastatic disease between the clusters defined by the first branch point of the clustering dendrogram (P =.005), and also among the 4 different clusters defined by the second branch points (P =.001). Conclusions: This approach suggests the existence of >2 subsets of high-grade pleomorphic STS, each with distinct clinical behavior. A composite gene set such as that described here may be useful to stratify STS in clinical trials, and may be of practical utility in patient management.

AB - Background: Metastatic propensity of soft tissue sarcoma (STS) is heterogeneous and may be determined by gene expression patterns that do not correlate well with morphology. The authors have reported gene expression patterns that distinguish 2 broad classes of clear cell renal carcinoma (ccRCC-gene set), and other patterns that can distinguish heterogeneity of serous ovarian carcinoma (OVCA-gene set) and aggressive fibromatosis (AF-gene set); however, clinical follow-up data were not available for these samples. Methods: In the current study, gene expression patterns in 73 samples of high-grade STS were examined using spotted cDNA microarray slides that contained 16,000 unique UniGene clusters. Approximately 50% of the genes present in the ccRCC-, OVCA-, and AF-gene sets were also represented in the data from this chip set, and these were combined to form a composite gene set of 278 probes. Results: Hierarchical clustering using this composite gene set suggested the existence of subsets of the STS samples. Analysis revealed differences in the time to development of metastatic disease between the clusters defined by the first branch point of the clustering dendrogram (P =.005), and also among the 4 different clusters defined by the second branch points (P =.001). Conclusions: This approach suggests the existence of >2 subsets of high-grade pleomorphic STS, each with distinct clinical behavior. A composite gene set such as that described here may be useful to stratify STS in clinical trials, and may be of practical utility in patient management.

KW - gene expression

KW - heterogeneity

KW - metastasis

KW - microarray

KW - prognosis

KW - sarcoma

KW - subgroups

UR - http://www.scopus.com/inward/record.url?scp=84865338879&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84865338879&partnerID=8YFLogxK

U2 - 10.1002/cncr.26733

DO - 10.1002/cncr.26733

M3 - Article

VL - 118

SP - 4235

EP - 4243

JO - Cancer

JF - Cancer

SN - 0008-543X

IS - 17

ER -